NEPHROGENEX INC's ticker is NRXGQ and the CUSIP is 640667101. A total of 14 filers reported holding NEPHROGENEX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $0 | -100.0% | 813 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | -66.7% | 813 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | -25.0% | 813 | +21.2% | 0.00% | – |
Q2 2015 | $4,000 | 0.0% | 671 | +18.1% | 0.00% | – |
Q1 2015 | $4,000 | -50.0% | 568 | 0.0% | 0.00% | – |
Q4 2014 | $8,000 | +166.7% | 568 | 0.0% | 0.00% | – |
Q3 2014 | $3,000 | 0.0% | 568 | 0.0% | 0.00% | – |
Q2 2014 | $3,000 | – | 568 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 1,052,966 | $6,992,000 | 2.44% |
TURNER INVESTMENTS LLC | 124,158 | $825,000 | 0.15% |
Visium Asset Management, LP | 660,000 | $4,382,000 | 0.06% |
Edge Wealth Management LLC | 500 | $3,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 75,000 | $498,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 9,100 | $60,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 13,625 | $90,000 | 0.00% |
BlackRock Investment Management, LLC | 671 | $4,000 | 0.00% |
VANGUARD GROUP INC | 88,526 | $588,000 | 0.00% |
CITIGROUP INC | 122 | $1,000 | 0.00% |